Cargando…

Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy

Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruppert, Mihály, Korkmaz-Icöz, Sevil, Li, Shiliang, Brlecic, Paige, Németh, Balázs Tamás, Oláh, Attila, Horváth, Eszter M., Veres, Gábor, Pleger, Sven, Grabe, Niels, Merkely, Béla, Karck, Matthias, Radovits, Tamás, Szabó, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331535/
https://www.ncbi.nlm.nih.gov/pubmed/30670980
http://dx.doi.org/10.3389/fphys.2018.01869
_version_ 1783387153432051712
author Ruppert, Mihály
Korkmaz-Icöz, Sevil
Li, Shiliang
Brlecic, Paige
Németh, Balázs Tamás
Oláh, Attila
Horváth, Eszter M.
Veres, Gábor
Pleger, Sven
Grabe, Niels
Merkely, Béla
Karck, Matthias
Radovits, Tamás
Szabó, Gábor
author_facet Ruppert, Mihály
Korkmaz-Icöz, Sevil
Li, Shiliang
Brlecic, Paige
Németh, Balázs Tamás
Oláh, Attila
Horváth, Eszter M.
Veres, Gábor
Pleger, Sven
Grabe, Niels
Merkely, Béla
Karck, Matthias
Radovits, Tamás
Szabó, Gábor
author_sort Ruppert, Mihály
collection PubMed
description Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the “gold standard” pressure unloading therapy. Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed. Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness. Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners.
format Online
Article
Text
id pubmed-6331535
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63315352019-01-22 Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy Ruppert, Mihály Korkmaz-Icöz, Sevil Li, Shiliang Brlecic, Paige Németh, Balázs Tamás Oláh, Attila Horváth, Eszter M. Veres, Gábor Pleger, Sven Grabe, Niels Merkely, Béla Karck, Matthias Radovits, Tamás Szabó, Gábor Front Physiol Physiology Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) – cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the “gold standard” pressure unloading therapy. Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed. Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness. Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331535/ /pubmed/30670980 http://dx.doi.org/10.3389/fphys.2018.01869 Text en Copyright © 2019 Ruppert, Korkmaz-Icöz, Li, Brlecic, Németh, Oláh, Horváth, Veres, Pleger, Grabe, Merkely, Karck, Radovits and Szabó. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Ruppert, Mihály
Korkmaz-Icöz, Sevil
Li, Shiliang
Brlecic, Paige
Németh, Balázs Tamás
Oláh, Attila
Horváth, Eszter M.
Veres, Gábor
Pleger, Sven
Grabe, Niels
Merkely, Béla
Karck, Matthias
Radovits, Tamás
Szabó, Gábor
Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_full Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_fullStr Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_full_unstemmed Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_short Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
title_sort comparison of the reverse-remodeling effect of pharmacological soluble guanylate cyclase activation with pressure unloading in pathological myocardial left ventricular hypertrophy
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331535/
https://www.ncbi.nlm.nih.gov/pubmed/30670980
http://dx.doi.org/10.3389/fphys.2018.01869
work_keys_str_mv AT ruppertmihaly comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT korkmazicozsevil comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT lishiliang comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT brlecicpaige comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT nemethbalazstamas comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT olahattila comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT horvatheszterm comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT veresgabor comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT plegersven comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT grabeniels comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT merkelybela comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT karckmatthias comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT radovitstamas comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy
AT szabogabor comparisonofthereverseremodelingeffectofpharmacologicalsolubleguanylatecyclaseactivationwithpressureunloadinginpathologicalmyocardialleftventricularhypertrophy